Nicholas Grund
President at Eurofins Transplant Genomics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Dave Knecht
I worked with Nik as both his VP of Finance and VP of Operations at Transplant Genomics. I was initially hesitant to take on a VP Operations role, but I did so because I trusted Nik to provide leadership and guidance as I took on the role. During my time working for Nik, I found him to be an extraordinary leader who is particularly strong in the areas of transformation, growth and leadership: * Transformation: Nik joined Transplant Genomics when the company was struggling. Processes and systems were not functioning optimally, there was no clarity on our target customers, and the team was not completely in place. Nik immediately took charge, building a team, providing focus on critical areas of the business, and providing clarity on our target customers. As a result, TGI achieved 10x growth during a 2-year period. * Communication: Nik is a storyteller and can convey complex ideas in ways that are clear and understandable by an entire organization. By being able to tell a story around supporting facts and data, Nik provides a convincing narrative for executives, owners and board members to achieve an objective - whether it is to raise funds, gain approval for a particular direction or increase staffing. * Leadership - Nik was trusted by his team. He builds long-lasting relationships, engages in team building as necessary and makes you feel like you are a valued resource. I've worked with many leaders and Nik has a gift for bringing together a team. If you are seeking a leader, whether it be as CEO, COO or in some other capacity, you would be very fortunate to have Nik leading your team.
Jeff D.
I had the privilege of working closely with Nicholas Grund during our time at Eurofins Transplant Genomics, where he served as the President and Business Unit Head. I am delighted to provide my highest recommendation for Nicholas, as he is truly an exceptional leader with a remarkable range of skills and abilities. Nicholas and I joined Transplant Genomics simultaneously, and it was immediately evident that he possessed the qualities of a Transformational Leader. His keen business acumen and visionary leadership played a pivotal role in turning around the business. What sets Nicholas apart is his multifaceted skill set, encompassing an in-depth understanding of organizational finance, clinical and scientific knowledge, logistics and operations, and commercial sales. I witnessed firsthand how Nicholas leveraged these diverse skills to orchestrate the rapid growth of Transplant Genomics, catapulting it into a category leader in a mere 15 months. This achievement is a testament to his strategic thinking and ability to drive results across various facets of the business. On a personal level, I found Nicholas to be one of the most inspirational and accessible leaders I have ever had the privilege of working with. During our hyper-growth phase at Transplant Genomics, he consistently made himself available, going above and beyond to provide guidance and support. His dedication to our team's success was unwavering, and his willingness to invest time and effort into our growth was truly commendable. Nicholas Grund's versatility, intensity, and business acumen make him a truly unique and competent executive in the biotech industry. I have no doubt that his leadership will continue to drive success and innovation in any endeavor he chooses to pursue. It was an honor to work alongside Nicholas, and I wholeheartedly recommend him to any organization seeking an exceptional leader who can transform and elevate their business.
Dave Knecht
I worked with Nik as both his VP of Finance and VP of Operations at Transplant Genomics. I was initially hesitant to take on a VP Operations role, but I did so because I trusted Nik to provide leadership and guidance as I took on the role. During my time working for Nik, I found him to be an extraordinary leader who is particularly strong in the areas of transformation, growth and leadership: * Transformation: Nik joined Transplant Genomics when the company was struggling. Processes and systems were not functioning optimally, there was no clarity on our target customers, and the team was not completely in place. Nik immediately took charge, building a team, providing focus on critical areas of the business, and providing clarity on our target customers. As a result, TGI achieved 10x growth during a 2-year period. * Communication: Nik is a storyteller and can convey complex ideas in ways that are clear and understandable by an entire organization. By being able to tell a story around supporting facts and data, Nik provides a convincing narrative for executives, owners and board members to achieve an objective - whether it is to raise funds, gain approval for a particular direction or increase staffing. * Leadership - Nik was trusted by his team. He builds long-lasting relationships, engages in team building as necessary and makes you feel like you are a valued resource. I've worked with many leaders and Nik has a gift for bringing together a team. If you are seeking a leader, whether it be as CEO, COO or in some other capacity, you would be very fortunate to have Nik leading your team.
Jeff D.
I had the privilege of working closely with Nicholas Grund during our time at Eurofins Transplant Genomics, where he served as the President and Business Unit Head. I am delighted to provide my highest recommendation for Nicholas, as he is truly an exceptional leader with a remarkable range of skills and abilities. Nicholas and I joined Transplant Genomics simultaneously, and it was immediately evident that he possessed the qualities of a Transformational Leader. His keen business acumen and visionary leadership played a pivotal role in turning around the business. What sets Nicholas apart is his multifaceted skill set, encompassing an in-depth understanding of organizational finance, clinical and scientific knowledge, logistics and operations, and commercial sales. I witnessed firsthand how Nicholas leveraged these diverse skills to orchestrate the rapid growth of Transplant Genomics, catapulting it into a category leader in a mere 15 months. This achievement is a testament to his strategic thinking and ability to drive results across various facets of the business. On a personal level, I found Nicholas to be one of the most inspirational and accessible leaders I have ever had the privilege of working with. During our hyper-growth phase at Transplant Genomics, he consistently made himself available, going above and beyond to provide guidance and support. His dedication to our team's success was unwavering, and his willingness to invest time and effort into our growth was truly commendable. Nicholas Grund's versatility, intensity, and business acumen make him a truly unique and competent executive in the biotech industry. I have no doubt that his leadership will continue to drive success and innovation in any endeavor he chooses to pursue. It was an honor to work alongside Nicholas, and I wholeheartedly recommend him to any organization seeking an exceptional leader who can transform and elevate their business.
Dave Knecht
I worked with Nik as both his VP of Finance and VP of Operations at Transplant Genomics. I was initially hesitant to take on a VP Operations role, but I did so because I trusted Nik to provide leadership and guidance as I took on the role. During my time working for Nik, I found him to be an extraordinary leader who is particularly strong in the areas of transformation, growth and leadership: * Transformation: Nik joined Transplant Genomics when the company was struggling. Processes and systems were not functioning optimally, there was no clarity on our target customers, and the team was not completely in place. Nik immediately took charge, building a team, providing focus on critical areas of the business, and providing clarity on our target customers. As a result, TGI achieved 10x growth during a 2-year period. * Communication: Nik is a storyteller and can convey complex ideas in ways that are clear and understandable by an entire organization. By being able to tell a story around supporting facts and data, Nik provides a convincing narrative for executives, owners and board members to achieve an objective - whether it is to raise funds, gain approval for a particular direction or increase staffing. * Leadership - Nik was trusted by his team. He builds long-lasting relationships, engages in team building as necessary and makes you feel like you are a valued resource. I've worked with many leaders and Nik has a gift for bringing together a team. If you are seeking a leader, whether it be as CEO, COO or in some other capacity, you would be very fortunate to have Nik leading your team.
Jeff D.
I had the privilege of working closely with Nicholas Grund during our time at Eurofins Transplant Genomics, where he served as the President and Business Unit Head. I am delighted to provide my highest recommendation for Nicholas, as he is truly an exceptional leader with a remarkable range of skills and abilities. Nicholas and I joined Transplant Genomics simultaneously, and it was immediately evident that he possessed the qualities of a Transformational Leader. His keen business acumen and visionary leadership played a pivotal role in turning around the business. What sets Nicholas apart is his multifaceted skill set, encompassing an in-depth understanding of organizational finance, clinical and scientific knowledge, logistics and operations, and commercial sales. I witnessed firsthand how Nicholas leveraged these diverse skills to orchestrate the rapid growth of Transplant Genomics, catapulting it into a category leader in a mere 15 months. This achievement is a testament to his strategic thinking and ability to drive results across various facets of the business. On a personal level, I found Nicholas to be one of the most inspirational and accessible leaders I have ever had the privilege of working with. During our hyper-growth phase at Transplant Genomics, he consistently made himself available, going above and beyond to provide guidance and support. His dedication to our team's success was unwavering, and his willingness to invest time and effort into our growth was truly commendable. Nicholas Grund's versatility, intensity, and business acumen make him a truly unique and competent executive in the biotech industry. I have no doubt that his leadership will continue to drive success and innovation in any endeavor he chooses to pursue. It was an honor to work alongside Nicholas, and I wholeheartedly recommend him to any organization seeking an exceptional leader who can transform and elevate their business.
Dave Knecht
I worked with Nik as both his VP of Finance and VP of Operations at Transplant Genomics. I was initially hesitant to take on a VP Operations role, but I did so because I trusted Nik to provide leadership and guidance as I took on the role. During my time working for Nik, I found him to be an extraordinary leader who is particularly strong in the areas of transformation, growth and leadership: * Transformation: Nik joined Transplant Genomics when the company was struggling. Processes and systems were not functioning optimally, there was no clarity on our target customers, and the team was not completely in place. Nik immediately took charge, building a team, providing focus on critical areas of the business, and providing clarity on our target customers. As a result, TGI achieved 10x growth during a 2-year period. * Communication: Nik is a storyteller and can convey complex ideas in ways that are clear and understandable by an entire organization. By being able to tell a story around supporting facts and data, Nik provides a convincing narrative for executives, owners and board members to achieve an objective - whether it is to raise funds, gain approval for a particular direction or increase staffing. * Leadership - Nik was trusted by his team. He builds long-lasting relationships, engages in team building as necessary and makes you feel like you are a valued resource. I've worked with many leaders and Nik has a gift for bringing together a team. If you are seeking a leader, whether it be as CEO, COO or in some other capacity, you would be very fortunate to have Nik leading your team.
Jeff D.
I had the privilege of working closely with Nicholas Grund during our time at Eurofins Transplant Genomics, where he served as the President and Business Unit Head. I am delighted to provide my highest recommendation for Nicholas, as he is truly an exceptional leader with a remarkable range of skills and abilities. Nicholas and I joined Transplant Genomics simultaneously, and it was immediately evident that he possessed the qualities of a Transformational Leader. His keen business acumen and visionary leadership played a pivotal role in turning around the business. What sets Nicholas apart is his multifaceted skill set, encompassing an in-depth understanding of organizational finance, clinical and scientific knowledge, logistics and operations, and commercial sales. I witnessed firsthand how Nicholas leveraged these diverse skills to orchestrate the rapid growth of Transplant Genomics, catapulting it into a category leader in a mere 15 months. This achievement is a testament to his strategic thinking and ability to drive results across various facets of the business. On a personal level, I found Nicholas to be one of the most inspirational and accessible leaders I have ever had the privilege of working with. During our hyper-growth phase at Transplant Genomics, he consistently made himself available, going above and beyond to provide guidance and support. His dedication to our team's success was unwavering, and his willingness to invest time and effort into our growth was truly commendable. Nicholas Grund's versatility, intensity, and business acumen make him a truly unique and competent executive in the biotech industry. I have no doubt that his leadership will continue to drive success and innovation in any endeavor he chooses to pursue. It was an honor to work alongside Nicholas, and I wholeheartedly recommend him to any organization seeking an exceptional leader who can transform and elevate their business.
Experience
-
Eurofins Transplant Genomics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
President
-
Jan 2021 - Nov 2022
Steered organizational change with strategic adaptation to evolving market demands, technology, and initiatives. Facilitated continuous improvements in operating efficiencies aligned with business objectives. Established stakeholder partnerships across healthcare system Drove sales, marketing, lab operations, client relationships, research and development, and medical services. Spearheaded 225% revenue growth with shift in operational focus to transplant biomarker products ● Reviewed… Show more Steered organizational change with strategic adaptation to evolving market demands, technology, and initiatives. Facilitated continuous improvements in operating efficiencies aligned with business objectives. Established stakeholder partnerships across healthcare system Drove sales, marketing, lab operations, client relationships, research and development, and medical services. Spearheaded 225% revenue growth with shift in operational focus to transplant biomarker products ● Reviewed market landscape to identify enhanced strategic direction ● Retrained and redeployed sales team to align with high value clients delivering unique value proposition ● Launched novel gene expression assay product to accelerate revenue growth Increased customer facing footprint 150% to more effectively educate and service current and potential customers ● Reviewed patients journey and implemented additional resources to education and service gaps ● Enhanced service by building internal mobile phlebotomy team to ensure consistency of sample preparation ● Added service liaison aligned to sales representatives to increase selling time and enhance customer service Transformed previous loss position to profitability with cross-functional growth strategies ● Collected employee feedback to re-engage staff and implement positive changes ● Pivoted company strategy to accelerate growth with market execution, product launches, and engagement ● Developed R&D pipeline strategy to release 2 new products annually Show less Steered organizational change with strategic adaptation to evolving market demands, technology, and initiatives. Facilitated continuous improvements in operating efficiencies aligned with business objectives. Established stakeholder partnerships across healthcare system Drove sales, marketing, lab operations, client relationships, research and development, and medical services. Spearheaded 225% revenue growth with shift in operational focus to transplant biomarker products ● Reviewed… Show more Steered organizational change with strategic adaptation to evolving market demands, technology, and initiatives. Facilitated continuous improvements in operating efficiencies aligned with business objectives. Established stakeholder partnerships across healthcare system Drove sales, marketing, lab operations, client relationships, research and development, and medical services. Spearheaded 225% revenue growth with shift in operational focus to transplant biomarker products ● Reviewed market landscape to identify enhanced strategic direction ● Retrained and redeployed sales team to align with high value clients delivering unique value proposition ● Launched novel gene expression assay product to accelerate revenue growth Increased customer facing footprint 150% to more effectively educate and service current and potential customers ● Reviewed patients journey and implemented additional resources to education and service gaps ● Enhanced service by building internal mobile phlebotomy team to ensure consistency of sample preparation ● Added service liaison aligned to sales representatives to increase selling time and enhance customer service Transformed previous loss position to profitability with cross-functional growth strategies ● Collected employee feedback to re-engage staff and implement positive changes ● Pivoted company strategy to accelerate growth with market execution, product launches, and engagement ● Developed R&D pipeline strategy to release 2 new products annually Show less
-
-
-
-
Company Owner & Consultant
-
May 2019 - Dec 2020
Collaborated with biotech organization clients to enhance portfolio of rare disease product candidates. Provided subject matter expertise to companies undergoing significant change. Generated $25M Series A capital through engaging articulation of value proposition ● Created comprehensive business plan to outline mission, vision, and long-term goals ● Prepared realistic, data-driven financial projections to demonstrate clear path to profitability ● Presented pitch deck to provide… Show more Collaborated with biotech organization clients to enhance portfolio of rare disease product candidates. Provided subject matter expertise to companies undergoing significant change. Generated $25M Series A capital through engaging articulation of value proposition ● Created comprehensive business plan to outline mission, vision, and long-term goals ● Prepared realistic, data-driven financial projections to demonstrate clear path to profitability ● Presented pitch deck to provide overview of company, the problems it solves, and market impact Show less Collaborated with biotech organization clients to enhance portfolio of rare disease product candidates. Provided subject matter expertise to companies undergoing significant change. Generated $25M Series A capital through engaging articulation of value proposition ● Created comprehensive business plan to outline mission, vision, and long-term goals ● Prepared realistic, data-driven financial projections to demonstrate clear path to profitability ● Presented pitch deck to provide… Show more Collaborated with biotech organization clients to enhance portfolio of rare disease product candidates. Provided subject matter expertise to companies undergoing significant change. Generated $25M Series A capital through engaging articulation of value proposition ● Created comprehensive business plan to outline mission, vision, and long-term goals ● Prepared realistic, data-driven financial projections to demonstrate clear path to profitability ● Presented pitch deck to provide overview of company, the problems it solves, and market impact Show less
-
-
-
AMAG Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Chief Commercial Officer (CCO)
-
Jan 2016 - May 2019
Managed commercial activities across four business units. Steered manufacturing and supply chain to ensure delivery of high quality and cost-effective products. Transformed care delivery by dismantling barriers to equitable health outcomes. Leveraged macro trends, research, analysis, and benchmarks to capitalize on market opportunities. Drove 20%+ annual growth with organizational transformation from single product to multiple BU company ● Conducted thorough analysis of business… Show more Managed commercial activities across four business units. Steered manufacturing and supply chain to ensure delivery of high quality and cost-effective products. Transformed care delivery by dismantling barriers to equitable health outcomes. Leveraged macro trends, research, analysis, and benchmarks to capitalize on market opportunities. Drove 20%+ annual growth with organizational transformation from single product to multiple BU company ● Conducted thorough analysis of business operations and market position to outline goals ● Implemented robust marketing and sales strategies to penetrate existing and new markets ● Identified potential challenges and risks to develop contingency plans and mitigate adverse impacts Improved efficiency with implementation of governance model ● Reviewed existing SOPs to assess strengths and weaknesses in decision making processes ● Worked with stakeholders and staff to get buy in and ensure smooth implementation ● Onboarded employees to familiarize with new model and responsibilities Launched product within 90 days of acquiring rights through rapid expansion of staffing ● Engaged external recruiters to identify role competencies for candidate screening ● Lead design of sales training program to teach clinical profile, market dynamics and selling skills ● Presented product to Private Insurers leading to 85% coverage within 6 months of launch Increased investor engagement with development of commercial messaging ● Researched client investment interests, risk tolerances, and values to locate potential opportunities ● Customized messaging across investor segments to highlight unique value propositions ● Created quarterly earnings reports to update investors on performance Show less Managed commercial activities across four business units. Steered manufacturing and supply chain to ensure delivery of high quality and cost-effective products. Transformed care delivery by dismantling barriers to equitable health outcomes. Leveraged macro trends, research, analysis, and benchmarks to capitalize on market opportunities. Drove 20%+ annual growth with organizational transformation from single product to multiple BU company ● Conducted thorough analysis of business… Show more Managed commercial activities across four business units. Steered manufacturing and supply chain to ensure delivery of high quality and cost-effective products. Transformed care delivery by dismantling barriers to equitable health outcomes. Leveraged macro trends, research, analysis, and benchmarks to capitalize on market opportunities. Drove 20%+ annual growth with organizational transformation from single product to multiple BU company ● Conducted thorough analysis of business operations and market position to outline goals ● Implemented robust marketing and sales strategies to penetrate existing and new markets ● Identified potential challenges and risks to develop contingency plans and mitigate adverse impacts Improved efficiency with implementation of governance model ● Reviewed existing SOPs to assess strengths and weaknesses in decision making processes ● Worked with stakeholders and staff to get buy in and ensure smooth implementation ● Onboarded employees to familiarize with new model and responsibilities Launched product within 90 days of acquiring rights through rapid expansion of staffing ● Engaged external recruiters to identify role competencies for candidate screening ● Lead design of sales training program to teach clinical profile, market dynamics and selling skills ● Presented product to Private Insurers leading to 85% coverage within 6 months of launch Increased investor engagement with development of commercial messaging ● Researched client investment interests, risk tolerances, and values to locate potential opportunities ● Customized messaging across investor segments to highlight unique value propositions ● Created quarterly earnings reports to update investors on performance Show less
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Vice President, Head of Specialty Care Business
-
Jun 2015 - Dec 2015
Spearheaded development strategy to improve portfolio offerings and maintain market leadership. Explored opportunities to foster awareness of ongoing health inequities and disparities. Worked with leadership team to create, implement, and manage programs designed to ensure fair treatment of faculty, staff, and trainees. Managed oncology, renal, biosurgery, and Lovenox franchises worth $2.7B+ ● Created and executed successful strategies to revitalize and sustain… Show more Spearheaded development strategy to improve portfolio offerings and maintain market leadership. Explored opportunities to foster awareness of ongoing health inequities and disparities. Worked with leadership team to create, implement, and manage programs designed to ensure fair treatment of faculty, staff, and trainees. Managed oncology, renal, biosurgery, and Lovenox franchises worth $2.7B+ ● Created and executed successful strategies to revitalize and sustain franchises ● Collaborated with cross-functional staff to play crucial role in growth drivers ● Utilized cutting edge technologies to increase profitability of legacy business
-
-
Senior Vice President, Asia Pacific & Canada
-
Mar 2013 - Jun 2015
Managed 11 international markets, including Australia, Canada, China, Japan, South Korea, Malaysia, Taiwan, and Singapore. Served in interim GM role in Japan region. Hired, trained, and mentored Country Managers in Japan, Australia, S Korea, Taiwan, and SE Asia. Delivered 110% profit vs forecasted with compelling, visionary strategies ● Accelerated revenue growth through development of patient identification program ● Gained reimbursement in Thailand and South Korea for Rare… Show more Managed 11 international markets, including Australia, Canada, China, Japan, South Korea, Malaysia, Taiwan, and Singapore. Served in interim GM role in Japan region. Hired, trained, and mentored Country Managers in Japan, Australia, S Korea, Taiwan, and SE Asia. Delivered 110% profit vs forecasted with compelling, visionary strategies ● Accelerated revenue growth through development of patient identification program ● Gained reimbursement in Thailand and South Korea for Rare Disease products ● Installed new country leadership teams in key markets and prioritized spending to high growth/profit segments
-
-
Senior Vice President, Commercial Optimization
-
Jun 2010 - Feb 2013
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Associate General Manager, Renal Business Unit
-
2009 - 2010
-
-
Vice President, Renal International Business
-
2008 - 2009
-
-
VP, Renal Commercial Operations
-
2005 - 2008
-
-
Senior Director of Finance, Renal & Endocrinology Business
-
2002 - 2005
-
-
-
Bayer
-
Chemical Manufacturing
-
700 & Above Employee
-
Manager of Financial Planning and Analysis
-
1995 - 2001
-
-
Education
-
D'Amore-McKim School of Business at Northeastern University
Master of Business Administration - MBA, Business
Community
